Malaria vaccine safety study in healthy adults
Treatments studied
Part of Infections clinical trials.
This study tests a new malaria vaccine to see if it is safe and how the body responds. It involves healthy adults in Burkina Faso who will be monitored closely after vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in good health, with a body mass index (BMI) between 18 and 30.
- You live in the study area for the whole study period.
- You agree to avoid pregnancy (if female) and not donate blood during the study.
- You have not had a malaria vaccine before and are not taking certain medications.
- You are willing to undergo tests for HIV, hepatitis B, hepatitis C, and sickle cell trait.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults living in Burkina Faso. If you qualify, the vaccine is given to see if it can protect you from malaria.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.